News

SMC Ltd. Announces Expansion of Sterile Fill Finish Capabilities, Unveiling State-of-the Art Facility in North Carolina

March 13, 2024

SMC Ltd. announces expansion of sterile fill finish capabilities, unveiling state-of-the-art facility in North Carolina. The facility enables SMC to offer a wider portfolio of services to its pharma clients including lab to market development, analytical services, device manufacture, fill finish, final assembly, and secondary packaging. The new facility compliments SMC’s footprint of global manufacturing capabilities and illustrates SMC’s commitment to the pharma services industry by offering high-speed, sterile fill finish lines with onsite formulation, compounding, and packaging capabilities. Read the full press release here.

SMC Will be Exhibiting at PharmaPack Paris and MDM West 2024 Trade Shows

December 7, 2023

SMC Ltd. will be exhibiting during the following upcoming trade shows: PharmaPack Paris, Booth #A80, January 24-25, Paris France 2024 MDM West, Booth #2831 from February 6-8, Anaheim, CA 2024 Our SME’s will be on-hand to answer questions and discuss our capabilities. If attending, we invite you to stop by our booth(s) to learn more about our contract manufacturing experience, patience centric auto injectors capabilities, and more.

SMC Exhibiting During PODD and PDA 2023 Trade Shows

September 18, 2023

SMC Ltd. will be exhibiting during the following upcoming trade shows: PODD, Booth #35, October 16-17, Boston, MA 2023 PDA, Booth #29 from October 17-18, Gothenburg, Sweden 2023 Our SME’s will be on-hand to answer questions and discuss our capabilities. If attending, we invite you to stop by our booth(s) to learn more about our contract manufacturing experience, patience centric auto injectors capabilities, and more.

SMC’s Senior Director Drug Delivery Provides Insights for MPO Article

July 10, 2023

Read the latest issue of Medical Product Outsourcing where our SME Meredith Canty, Senior Director Drug Delivery, provides her insights for the article. “A Combined Effort for Drug Delivery and Combo Product Technology – examining the market forces, testing strategies, regulatory concerns, and future of drug-device combination products.” Read more here

Join us for the PharmaEd Combination Product Summit 2023

May 2, 2023

Join us for the PharmaEd Combination Product Summit 2023 on Wednesday, May 17, at 1:00 pm EST. During the summit, Asmita Khanolkar, Senior Director at SMC, will be presenting “An Integrated Approach to Combination Product Development.” Don’t miss out on this informative presentation! Click here to register now.

Ensure Speed and Success with Your Drug Delivery Project: Best Practices for Establishing a Firm Foundation with a Contract Manufacturer – Webinar

April 20, 2023

Join us for a webinar on Thursday, May 18 at 11:00 a.m. Eastern, where we will be discussing “Ensure Speed and Success with Your Drug Delivery Project: Best Practices for Establishing a Firm Foundation with a Contract Manufacturer.” As drug delivery projects become increasingly complex, it’s more important than ever to have a strong foundation in place with your contract manufacturer. During this webinar, we’ll cover best practices for working with a contract manufacturer, including: • How to choose the right partner for your project • Establishing clear commination and project goals • Tips for optimizing the manufacturing process • Ensuring regulatory compliance and quality control • Determining your automation Our expert panel includes industry leaders with years of experience in pharmaceutical manufacturing and drug delivery. You want to miss this opportunity to learn from the best! Register now and secure your spot for this informative and insightful webinar. We…

Uri Baruch Named as New Vice President and General Manager of SMC Ltd.’s UK Division

April 19, 2023

Cambridge, United Kingdom – SMC Ltd., a global medical device and pharmaceutical services company, is proud to announce the appointment of Uri Baruch as the new Vice President and General Manager of its European Division, which includes Oval Medical Technologies and Cambridge Pharma Ltd. (CPL), effective immediately. “Uri’s appointment comes at an important time for SMC as we continue to expand our presence in the pharmaceutical industry and pursue new opportunities for growth. We are excited to welcome him to the SMC team,” said SMC CEO Chetan N. Patel. “Uri will continue the great work that has been done by our European teams to date and his deep industry expertise and passion for advancing patient care make him the perfect fit to lead the SMC Europe teams. We are confident that he will help us achieve our goals and drive continued growth for our Company.” Read the full press release…

SMC Sponsors StrykerTalks Podcast powered by Device Talks

April 18, 2023

Listen to the latest StrykerTalks podcast episode, sponsored by SMC Ltd., where CEO Kevin Lobo says he’s seeing the skies clearing a bit for the MedicalDevice industry and hospitals though challenges remain. Earnings are improving, and new ProductInnovation is producing a super-cycle of new products. Listen now to hear Lobo’s perspective on Stryker’s position globally and in emerging markets, tailwinds from the COVID-19 pandemic, and innovation factors that fuel continued growth within the organization and beyond. He also shares the company’s measured M&A strategy and its position in Orthopedic SurgicalRobotics. Listen Here.

SMC Ltd. Featured in Springer Nature’s “Journal of Pharmaceutical Sciences.”

April 13, 2023

Read our latest original research article in Springer Nature “Journal of Pharmaceutical Sciences” by Asmita Khanolkar, Susie White and Elizabeth Margerison titled “A Novel Method to Optimize Drug Delivery for Parenteral Products.” Pharm Res (2023). Read it now

SMC Announces Opening of Cambridge Pharma

June 7, 2022

SMC announces  the opening of Cambridge Pharma a new business offering pharmaceutical development services, including sterile fill-finish. The new 20,000 sq ft facility located at the Cambridge Research Park, UK, includes a purpose-built sterile fill-finish facility, a process development laboratory and an analytical laboratory. Services include process development and scale up, sterile fill-finish for clinical trials, QC and stability testing and QP release of clinical trials supplies. Read the fill press release here.